Drug development: describes the process of developing a new drug that energetically targets a specific weakness in a cell. The process consist of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
-
Over the past decade, flow cytometry has undergone transformative advancements, notably with the adoption of spectral flow cytometry and the emergence of next-generation imaging cytometers....
Standard bioassays often fall short when evaluating T cell engagers due to their diverse mechanisms of actions (MOAs) and functional complexity. To generate meaningful preclinical data, cont...
Mass Photometry (MP) and Macro Mass Photometry (MMP) are complementary, label-free techniques that analyze biomolecules and therapeutic vectors directly in solution with single-particle reso...
Our experience collaborating with oncology and immunology leaders in the pharmaceutical and biotech space has revealed the numerous challenges in every stage of drug development. From target...
SEP 17, 2025 | 11:15 AM
C.E. CREDITS
Traditional animal models and simplified cell cultures often fail to capture human biology, limiting progress in biomedical research and drug development. Emerging microfluidic "Organ-o...
Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights....
The discovery of covalent inhibitors has become a powerful strategy in drug development due to their ability to form irreversible bonds with target proteins, resulting in enhanced therapeuti...
Biomarkers are no longer just exploratory tools-they're becoming strategic assets in drug development and clinical trials. Join a panel of industry thought leaders as they explore how biomar...
In advanced therapy development, blood samples are essential to gain molecular insights. RNA and biomarker profiles are highly sensitive to preanalytical variables—such as collection,...
BrainXell offers the most comprehensive portfolio of high-purity iPSC-derived human neurons and glia, sourced from control, edited and disease lines, to advance translational research and dr...
Join us for an enlightening session on the latest advancements in organoid research and drug discovery! Discover transformative applications, emerging trends, and common challenges in organo...
Solute carriers include numerous uptake transporters that serve as major regulators of drug absorption, disposition, and clearance. Indeed, drug interactions or genetic variation that alter...
SEP 18, 2024 | 9:00 AM
C.E. CREDITS
The disposition of antibody-based therapeutics is generally determined by both target-mediated and non-target processes, the latter being an often-overlooked aspect. Target-independent liabi...
Unlocking the potential of mRNA technology is revolutionizing medicine and biotechnology. Solid-phase in vitro transcription enables scalability and automation, making it a valuable tool for...
Analytical Ultracentrifugation (AUC) stands as a cornerstone technique in the realm of molecular and particle analysis, offering unparalleled insights into the size, shape, and interactions...
Transmembrane proteins (TPs) serve as crucial conduits between the internal and external environments of cells, regulating ion and molecule passage and orchestrating cellular responses to ex...
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Oligonucleotide therapeutics have emerged as a promising novel class of drugs to treat a wide range of diseases. The development of these therapeutics relies on the proper use of chemical bu...